Correlation Between Pmv Pharmaceuticals and AnaptysBio

Can any of the company-specific risk be diversified away by investing in both Pmv Pharmaceuticals and AnaptysBio at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pmv Pharmaceuticals and AnaptysBio into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Pmv Pharmaceuticals and AnaptysBio, you can compare the effects of market volatilities on Pmv Pharmaceuticals and AnaptysBio and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pmv Pharmaceuticals with a short position of AnaptysBio. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pmv Pharmaceuticals and AnaptysBio.

Diversification Opportunities for Pmv Pharmaceuticals and AnaptysBio

0.92

Correlation Coefficient

Pmv Pharmaceuticals  AnaptysBio

Almost no diversification

The 3 months correlation between Pmv and AnaptysBio is 0.92. Overlapping area represents the amount of risk that can be diversified away by holding Pmv Pharmaceuticals and AnaptysBio in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on AnaptysBio and Pmv Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pmv Pharmaceuticals are associated (or correlated) with AnaptysBio. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of AnaptysBio has no effect on the direction of Pmv Pharmaceuticals i.e., Pmv Pharmaceuticals and AnaptysBio go up and down completely randomly.

Pair Corralation between Pmv Pharmaceuticals and AnaptysBio

Given the investment horizon of 90 days Pmv Pharmaceuticals is expected to generate 1.22 times more return on investment than AnaptysBio. However, Pmv Pharmaceuticals is 1.22 times more volatile than AnaptysBio. It trades about 0.18 of its potential returns per unit of risk. AnaptysBio is currently generating about 0.1 per unit of risk. If you would invest  94.00  in Pmv Pharmaceuticals on May 5, 2025 and sell it today you would earn a total of  46.00  from holding Pmv Pharmaceuticals or generate 48.94% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Strong
Accuracy	100.0%
Values	Daily Returns

Pmv Pharmaceuticals  vs.  AnaptysBio

Pmv Pharmaceuticals

Risk-Adjusted Performance

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Pmv Pharmaceuticals are ranked lower than 14 (%) of all global equities and portfolios over the last 90 days. Even with relatively unfluctuating basic indicators, Pmv Pharmaceuticals reported solid returns over the last few months and may actually be approaching a breakup point.

AnaptysBio

Risk-Adjusted Performance

OK

Compared to the overall equity markets, risk-adjusted returns on investments in AnaptysBio are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, AnaptysBio sustained solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Pmv Pharmaceuticals and AnaptysBio

The main advantage of trading using opposite Pmv Pharmaceuticals and AnaptysBio positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pmv Pharmaceuticals position performs unexpectedly, AnaptysBio can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in AnaptysBio will offset losses from the drop in AnaptysBio's long position.

The idea behind Pmv Pharmaceuticals and AnaptysBio pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.